Sensyne Health Plc (LON: SENS) has become a Strategic Partner of Microsoft after extending its existing association with the tech company.
- The UK Clinical AI company, along with Microsoft, will work to further develop and refine its clinical AI and health cloud technologies.
- The association will supportSensyneto improve, augment, and reduce the cost of patient care.
- It will also enhance the capabilityof the company to create accessible and highly configurable healthcare technologies that are universally deployable and able to meet local, clinical, and regulatory needs.
- On 28 October 2020, the stocks of the company surgedby 10.85% from its previous closing, hovering at around GBX 117.50at 08:13 AM GMT+1.
_06_29_2022_17_04_20_968522.png "Food Stocks To Eye Amid Concerns Over Safety Standards")
_06_29_2022_16_50_47_873085.png "Gold Stocks To Watch As UK Sanctions Russian Gold Exports")
_06_23_2022_20_02_10_144615.png "Which Stocks are in focus as manufacturing output falls?")
_06_22_2022_18_43_54_315559.png "Stock To Watch As Ofgem Plans To Prevent Company Closures")
_06_22_2022_18_38_48_326419.png "Rolls-Royce (LON: RR.) stock trending as it announces £2,000 for staff")
Be the First to Comment